News
A recent article in The Brussel Times shows why it is time for EU Ministries of Health to “opt-in” to the new remanufacturing regulations of the MDR.
4. May 2021
A recent article in The Brussel Times shows why it is time for EU Ministries of Health to “opt-in” to the new remanufacturing regulations of the MDR.
The European “Green Deal” is the European Union’s most important policy platform – the EU wants to become emission-free by 2050. But the new EU Circular Economy Action Plan musn´t grind to a halt at the gates of the health care sector.
Entitled "From Single-Use Product to Valuable Asset: How Hospitals Can Keep Medical Devices in Circulation Cost-Effectively", the article explains why used single-use medical devices should not automatically be regarded as waste. Particularly for complex devices such as EP catheters and ultrasonic shears, Medical Remanufacturing can provide hospitals with an additional opportunity to keep products in circulation for longer while unlocking both economic and environmental benefits.
Among other topics, the article explores why the sale of suitable used medical devices can represent a distinct step within the circular economy and why sustainable solutions in everyday hospital practice are most effective when they can be integrated seamlessly into existing workflows.
Medical Remanufacturing combines resource conservation, cost efficiency, and validated processes, demonstrating how a product that might otherwise be considered waste can once again become a valuable asset.
The full article can be found in the latest edition of Klinergie Magazine:
